References
- Proceedings of the 4th World Symposium on Pulmonary Hypertension, February 2008, Dana Point, California, USA. J. Am. Coll. Cardiol.54(Suppl. 1), S1–S117 (2009).
- D’Alonzo GE, Barst RJ, Ayres SM et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann. Intern. Med.115(5), 343–349 (1991).
- Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur. Respir. J.35(5), 1079–1087 (2010).
- Benza RL, Miller DP, Gomberg-Maitland M et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation122(2), 164–172 (2010).
- Hoeper MM, Lee SH, Voswinckel R et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J. Am. Coll. Cardiol.48(12), 2546–2552 (2006).
- Newman JH, Trembath RC, Morse JA et al. Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J. Am. Coll. Cardiol.43, 33S–39S (2004).
- Condliffe R, Kiely DG, Peacock AJ et al. Connective tissue disease-related pulmonary arterial hypertension in the modern treatment era. Am. J. Respir. Crit. Care Med.179, 151–157 (2009).
- Ohlsson A, Kubo SH, Steinhaus D et al. Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. Eur. Heart J.22, 942–954 (2001).
- Magalski A, Adamson P, Gadler F et al. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: 12-month follow-up in a multi-center trial of chronic heart failure patients. J. Card. Fail.8, 63–70 (2002).
- Frantz RP, Benza RL, Kjellström B et al. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension. J. Heart Lung Transplant.27(7), 780–788 (2008).
- Karamanoglu M, McGoon M, Frantz RP et al. Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension. Chest132(1), 37–43 (2007).
- Stahlberg M, Damgaard M, Ersgard D et al. Estimating changes in cardiac output using an implanted hemodynamic monitor in heart failure patients. Scand. Cardiovasc. J.44, 201–208 (2010).
- Kjellstrom B, Linde C, Bennett T, Ohlsson A, Ryden L. Six years follow-up of an implanted SvO(2) sensor in the right ventricle. Eur. J. Heart Fail.6(5), 627–634 (2004).
- Parsa CJ, Daneshmand MA, Lima B, Balsara K, McCann RL, Hughes GC. Utility of remote wireless pressure sensing for endovascular leak detection after endovascular thoracic aneurysm repair. Ann. Thorac. Surg.89(2), 446–452 (2010).
- Verdejo HE, Castro PF, Concepci R et al. Comparison of a radiofrequency-based wireless pressure sensor to Swan-Ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. J. Am. Coll. Cardiol.50(25), 2375–2382 (2007).
- Macchia A, Marchioli R, Tognoni G et al. Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed. Am. Heart J.159(2), 245–257 (2010).
- Grimminger F, Schermuly RT. PDGF receptor and its antagonists: role in treatment of PAH. Adv. Exp. Med. Biol.661, 435–446 (2010).
- Chhina MK, Nargues W, Grant GM, Nathan SD. Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension. Future Cardiol.6(1), 19–35 (2010).